AU2019228625B2 - Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes - Google Patents

Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes Download PDF

Info

Publication number
AU2019228625B2
AU2019228625B2 AU2019228625A AU2019228625A AU2019228625B2 AU 2019228625 B2 AU2019228625 B2 AU 2019228625B2 AU 2019228625 A AU2019228625 A AU 2019228625A AU 2019228625 A AU2019228625 A AU 2019228625A AU 2019228625 B2 AU2019228625 B2 AU 2019228625B2
Authority
AU
Australia
Prior art keywords
nucleosome
histone
biological sample
disease
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019228625A
Other languages
English (en)
Other versions
AU2019228625A1 (en
Inventor
Martis William COWLES
Nathan W. HALL
Andrea L. JOHNSTONE
Michael-Christopher KEOGH
Matthew R. MARUNDE
Zu-Wen SUN
Matthew F. WHELIHAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epicypher Inc
Original Assignee
Epicypher Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicypher Inc filed Critical Epicypher Inc
Publication of AU2019228625A1 publication Critical patent/AU2019228625A1/en
Application granted granted Critical
Publication of AU2019228625B2 publication Critical patent/AU2019228625B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/31—Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.1.31)
    • C12Y301/31001—Micrococcal nuclease (3.1.31.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/18—Post-translational modifications [PTMs] in chemical analysis of biological material citrullination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Ecology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2019228625A 2018-03-01 2019-03-01 Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes Active AU2019228625B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862637066P 2018-03-01 2018-03-01
US62/637,066 2018-03-01
PCT/US2019/020283 WO2019169263A1 (en) 2018-03-01 2019-03-01 Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes

Publications (2)

Publication Number Publication Date
AU2019228625A1 AU2019228625A1 (en) 2020-09-03
AU2019228625B2 true AU2019228625B2 (en) 2024-11-07

Family

ID=67805943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019228625A Active AU2019228625B2 (en) 2018-03-01 2019-03-01 Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes

Country Status (10)

Country Link
US (2) US10787697B2 (cg-RX-API-DMAC7.html)
EP (2) EP3759249B1 (cg-RX-API-DMAC7.html)
JP (1) JP7376493B2 (cg-RX-API-DMAC7.html)
CN (1) CN111918971B (cg-RX-API-DMAC7.html)
AU (1) AU2019228625B2 (cg-RX-API-DMAC7.html)
CA (1) CA3091807A1 (cg-RX-API-DMAC7.html)
DK (2) DK4215621T3 (cg-RX-API-DMAC7.html)
ES (2) ES2960550T3 (cg-RX-API-DMAC7.html)
FI (2) FI3759249T3 (cg-RX-API-DMAC7.html)
WO (1) WO2019169263A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230003735A1 (en) * 2019-12-02 2023-01-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
US12636417B2 (en) 2020-09-21 2026-05-26 Belgian Volition Srl Device for inline monitoring of free nucleosomes in blood
CN112359092B (zh) * 2020-10-22 2023-09-19 中国农业科学院农业基因组研究所 一种基因组短片段文库的构建方法
CA3195344A1 (en) * 2020-11-02 2022-05-05 Matthew R. MARUNDE Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion
GB202108185D0 (en) * 2021-06-08 2021-07-21 Belgian Volition Sprl Standardisation of nucleosome assays using biologically derived calibrants
WO2023159045A1 (en) * 2022-02-15 2023-08-24 Epicypher, Inc. Engineered recombinant protein-binding domains as detection reagents
WO2024042208A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for the detection of dementia
EP4602370A1 (en) * 2022-10-12 2025-08-20 Epicypher, Inc. High efficiency antibodies for chromatin targets
EP4639173A1 (en) * 2022-12-19 2025-10-29 Belgian Volition SRL Calibration
EP4689160A1 (en) * 2023-04-03 2026-02-11 Belgian Volition SRL Recombinant nucleosome materials

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160341743A1 (en) * 2014-02-03 2016-11-24 The University Of Chicago Compositions and methods for quantitative assessment of dna-protein complex density

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1008748A (en) 1910-06-15 1911-11-14 Christian Keene Snavely Shade-roller.
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
WO2011016869A1 (en) 2009-08-06 2011-02-10 Kamran Tahamtanzadeh Methods and compositions for drug discovery
EP2621942A4 (en) * 2010-09-29 2015-01-21 Gen Hospital Corp MEANS FOR PROVIDING CONTROLS AND STANDARDS FOR IMMUNE PRECIPITATION ASSAYS
GB201115099D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
EP2859139B1 (en) 2012-06-06 2018-08-01 The Trustees Of Princeton University Dna barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof
US9745384B2 (en) * 2012-12-20 2017-08-29 The Brigham And Women's Hospital, Inc. Peptides useful for modulating histone demethylase function
GB201303575D0 (en) * 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes
GB201400522D0 (en) * 2014-01-13 2014-02-26 Proteros Biostructure Gmbh Nucleosome substrate assays
GB201511512D0 (en) 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell-free nucleosomes as biomarkers
WO2017034970A1 (en) * 2015-08-21 2017-03-02 The General Hospital Corporation Combinatorial single molecule analysis of chromatin
GB201518665D0 (en) * 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for enrichment of cell free nucleosomes
EP3371601A1 (en) 2015-11-05 2018-09-12 Epizyme Inc Flow cytometry for monitoring histone h3 methylation status

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160341743A1 (en) * 2014-02-03 2016-11-24 The University Of Chicago Compositions and methods for quantitative assessment of dna-protein complex density

Also Published As

Publication number Publication date
US10787697B2 (en) 2020-09-29
DK4215621T3 (da) 2025-08-04
JP2021515888A (ja) 2021-06-24
CN111918971A (zh) 2020-11-10
EP4215621A1 (en) 2023-07-26
CA3091807A1 (en) 2019-09-06
EP3759249B1 (en) 2023-08-30
ES3036655T3 (en) 2025-09-23
CN111918971B (zh) 2024-09-03
EP4215621B1 (en) 2025-05-28
US20200071745A1 (en) 2020-03-05
ES2960550T3 (es) 2024-03-05
AU2019228625A1 (en) 2020-09-03
FI3759249T3 (fi) 2023-10-11
US20210010058A1 (en) 2021-01-14
FI4215621T3 (fi) 2025-07-28
EP3759249A1 (en) 2021-01-06
US12104199B2 (en) 2024-10-01
DK3759249T3 (da) 2023-10-30
JP7376493B2 (ja) 2023-11-08
WO2019169263A1 (en) 2019-09-06
EP3759249A4 (en) 2021-11-24

Similar Documents

Publication Publication Date Title
US12104199B2 (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
JP2021515888A5 (cg-RX-API-DMAC7.html)
US20230407406A1 (en) Methods for Quantification of Nucleosome Modifications and Mutations at Genomic Loci and Clinical Applications Thereof
ES2808651T3 (es) Composiciones y métodos para la evaluación cuantitativa de la densidad del complejo de ADN-proteína
US20260035731A1 (en) Dna-barcoded nucleosomes for chromatin mapping assays
EP3664828A1 (en) Hdac6 and protein aggregation
Sharma et al. Genetically encoded fluorescent reporter for polyamines
Cappelletti et al. Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls
Tan et al. MORC2 is a phosphorylation-dependent DNA compaction machine
HK40098174A (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
HK40098174B (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
HK40045196A (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
HK40045196B (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
Nechifor et al. Crosslinking of translation factor EF-G to proteins of the bacterial ribosome before and after translocation
US20220049311A1 (en) Chromatin mapping assays and kits using long-read sequencing

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)